385 related articles for article (PubMed ID: 29778981)
1. Walking the line: The fate of nanomaterials at biological barriers.
Meng H; Leong W; Leong KW; Chen C; Zhao Y
Biomaterials; 2018 Aug; 174():41-53. PubMed ID: 29778981
[TBL] [Abstract][Full Text] [Related]
2. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
Wang Y; Cai R; Chen C
Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
[TBL] [Abstract][Full Text] [Related]
3. Physical and biochemical insights on DNA structures in artificial and living systems.
Chen N; Li J; Song H; Chao J; Huang Q; Fan C
Acc Chem Res; 2014 Jun; 47(6):1720-30. PubMed ID: 24588263
[TBL] [Abstract][Full Text] [Related]
4. Biophysicochemical perspective of nanoparticle compatibility: a critically ignored parameter in nanomedicine.
Hassan S; Singh AV
J Nanosci Nanotechnol; 2014 Jan; 14(1):402-14. PubMed ID: 24730271
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiologic mechanisms of biomedical nanomaterials.
Wang L; Chen C
Toxicol Appl Pharmacol; 2016 May; 299():30-40. PubMed ID: 26827823
[TBL] [Abstract][Full Text] [Related]
6. Nano-bio interactions: the implication of size-dependent biological effects of nanomaterials.
Wang X; Cui X; Zhao Y; Chen C
Sci China Life Sci; 2020 Aug; 63(8):1168-1182. PubMed ID: 32458255
[TBL] [Abstract][Full Text] [Related]
7. Nano-bio surface interactions, cellular internalisation in cancer cells and e-data portals of nanomaterials: A review.
Yadav RD; Chaudhary A
IET Nanobiotechnol; 2021 Aug; 15(6):519-531. PubMed ID: 34694743
[TBL] [Abstract][Full Text] [Related]
8. Relevance of Physicochemical Characterization of Nanomaterials for Understanding Nano-cellular Interactions.
Louro H
Adv Exp Med Biol; 2018; 1048():123-142. PubMed ID: 29453536
[TBL] [Abstract][Full Text] [Related]
9. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
Westmeier D; Stauber RH; Docter D
Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323
[TBL] [Abstract][Full Text] [Related]
10. Property-Activity Relationship of Black Phosphorus at the Nano-Bio Interface: From Molecules to Organisms.
Qu G; Xia T; Zhou W; Zhang X; Zhang H; Hu L; Shi J; Yu XF; Jiang G
Chem Rev; 2020 Feb; 120(4):2288-2346. PubMed ID: 31971371
[TBL] [Abstract][Full Text] [Related]
11. Impact of copper oxide nanomaterials on differentiated and undifferentiated Caco-2 intestinal epithelial cells; assessment of cytotoxicity, barrier integrity, cytokine production and nanomaterial penetration.
Ude VC; Brown DM; Viale L; Kanase N; Stone V; Johnston HJ
Part Fibre Toxicol; 2017 Aug; 14(1):31. PubMed ID: 28835236
[TBL] [Abstract][Full Text] [Related]
12. Preclinical hazard evaluation strategy for nanomedicines.
Siegrist S; Cörek E; Detampel P; Sandström J; Wick P; Huwyler J
Nanotoxicology; 2019 Feb; 13(1):73-99. PubMed ID: 30182784
[TBL] [Abstract][Full Text] [Related]
13. Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity.
Wang A; Marinakos SM; Badireddy AR; Powers CM; Houck KA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):430-48. PubMed ID: 23661551
[TBL] [Abstract][Full Text] [Related]
14. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.
Johnston H; Brown D; Kermanizadeh A; Gubbins E; Stone V
J Control Release; 2012 Dec; 164(3):307-13. PubMed ID: 22940205
[TBL] [Abstract][Full Text] [Related]
15. Challenges facing nanotoxicology and nanomedicine due to cellular diversity.
Akhtar MJ; Ahamed M; Alhadlaq HA
Clin Chim Acta; 2018 Dec; 487():186-196. PubMed ID: 30291894
[TBL] [Abstract][Full Text] [Related]
16. Elasticity regulates nanomaterial transport as delivery vehicles: Design, characterization, mechanisms and state of the art.
Nie D; Liu C; Yu M; Jiang X; Wang N; Gan Y
Biomaterials; 2022 Dec; 291():121879. PubMed ID: 36343607
[TBL] [Abstract][Full Text] [Related]
17. The nanoparticle biomolecule corona: lessons learned - challenge accepted?
Docter D; Westmeier D; Markiewicz M; Stolte S; Knauer SK; Stauber RH
Chem Soc Rev; 2015 Oct; 44(17):6094-121. PubMed ID: 26065524
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for imaging, sensing, and therapeutic intervention.
Bogart LK; Pourroy G; Murphy CJ; Puntes V; Pellegrino T; Rosenblum D; Peer D; Lévy R
ACS Nano; 2014 Apr; 8(4):3107-22. PubMed ID: 24641589
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
Nguyen NHA; Falagan-Lotsch P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility and nanostructured materials: applications in nanomedicine.
Adabi M; Naghibzadeh M; Adabi M; Zarrinfard MA; Esnaashari SS; Seifalian AM; Faridi-Majidi R; Tanimowo Aiyelabegan H; Ghanbari H
Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):833-842. PubMed ID: 27247194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
